Don't get your hopes up too high. While it isn't too late it is looking more and more like UNS has missed another one. We won't win them all but we do need to be landing more of these near-term deals. Fingers crossed Alan pulls this out of his butt! I'm very disappointed the company hasn't even started the FDA approval process yet on AIDs.
UNS Price at posting:
57.5¢ Sentiment: Hold Disclosure: Held
